Corrigendum to "EGFR-TKI down-regulates PD-L1 in EGFR mutant NSCLC through inhibiting NF-κB" [Biochem. Biophys. Res. Commun. 463(1-2) (2015) 95-101].

导出 LinkOut

翻译打印收藏纠错

第一作者： Kailong,Lin

第一单位： Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China.

作者： Kailong,Lin ^[1] ; Jianan,Cheng ^[1] ; Tao,Yang ^[1] ; Yongsheng,Li ^[1] ; Bo,Zhu ^[2]

作者单位： Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China. ^[1] Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China. Electronic address: bo.zhu@tmmu.edu.cn. ^[2]

DOI 10.1016/j.bbrc.2022.09.023

PMID 36114047

发布时间 2022-10-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biochemical and biophysical research communications

2022年629卷

189页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Corrigendum to "EGFR-TKI down-regulates PD-L1 in EGFR mutant NSCLC through inhibiting NF-κB" [Biochem. Biophys. Res. Commun. 463(1-2) (2015) 95-101].

Biochemical and biophysical research communications

相似文献

Biochemical and biophysical research communications

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Corrigendum to "EGFR-TKI down-regulates PD-L1 in EGFR mutant NSCLC through inhibiting NF-κB" [Biochem. Biophys. Res. Commun. 463(1-2) (2015) 95-101].

Biochemical and biophysical research communications

相似文献

Biochemical and biophysical research communications

相关期刊

检索历史清除